Global Fetal Bovine Serum (FBS) for Cell Culture Supply, Demand and Key Producers, 2023-2029
The global Fetal Bovine Serum (FBS) for Cell Culture market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells. Fetal bovine serum has been irreplaceable media in cell culture industry. The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry.
The manufacturers of FBS are concentrated in North America, Australia, New Zealand and South America. The growth of FBS production has been modest for the past years, due to the deficiency of raw material supply. The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture.
Fetal Bovine Serum (FBS) is a widely-used growth supplement for cell culture media that provides many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
This report studies the global Fetal Bovine Serum (FBS) for Cell Culture production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fetal Bovine Serum (FBS) for Cell Culture, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fetal Bovine Serum (FBS) for Cell Culture that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fetal Bovine Serum (FBS) for Cell Culture total production and demand, 2018-2029, (Tons)
Global Fetal Bovine Serum (FBS) for Cell Culture total production value, 2018-2029, (USD Million)
Global Fetal Bovine Serum (FBS) for Cell Culture production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Fetal Bovine Serum (FBS) for Cell Culture consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Fetal Bovine Serum (FBS) for Cell Culture domestic production, consumption, key domestic manufacturers and share
Global Fetal Bovine Serum (FBS) for Cell Culture production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Fetal Bovine Serum (FBS) for Cell Culture production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Fetal Bovine Serum (FBS) for Cell Culture production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global Fetal Bovine Serum (FBS) for Cell Culture market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Cytiva, Biowest, Moregate BioTech, ExCell Bio, Internegocios, Tissue Culture Biologicals and Gemini, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fetal Bovine Serum (FBS) for Cell Culture market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Fetal Bovine Serum (FBS) for Cell Culture Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Fetal Bovine Serum (FBS) for Cell Culture Market, Segmentation by Type
USA-sourced
South America-sourced
Australia-sourced
Others
Global Fetal Bovine Serum (FBS) for Cell Culture Market, Segmentation by Application
Scientific Research
Industrial Production
Companies Profiled:
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Animal Technologies
RMBIO
Bio Nutrientes Brasil
Serana
WISENT
PAN-Biotech
Zhejiang Tianhang Biotechnology
Lanzhou Minhai
Peak Serum
Jin Yuan Kang
Key Questions Answered
1. How big is the global Fetal Bovine Serum (FBS) for Cell Culture market?
2. What is the demand of the global Fetal Bovine Serum (FBS) for Cell Culture market?
3. What is the year over year growth of the global Fetal Bovine Serum (FBS) for Cell Culture market?
4. What is the production and production value of the global Fetal Bovine Serum (FBS) for Cell Culture market?
5. Who are the key producers in the global Fetal Bovine Serum (FBS) for Cell Culture market?